Executive Summary
132 corporate events are scheduled for May 26, 2026: 127 financial results and 5 board meetings. Companies on the calendar include Aartech Solonics Limited, A B Infrabuild Limited, Aequs Limited, AIA Engineering Limited, Alankit Limited, Alkali Metals Limited and 123 others.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior India Quarterly Results BSE NSE Announcements digest from May 25, 2026.
Scheduled Events (132)
Companies with corporate events on the calendar for this day.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the quarter and year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026 and to recommend dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, and other business matters
To consider and approve the financial results for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the audited financial results for the year ended March 31, 2026, dividend and other business matters
To consider and approve the audited financial results for the quarter and year ended March 31, 2026, dividend and Fund Raising
Brainbees Solutions Limited has informed the Exchange about Board Meeting to be held on May 26, 2026, to inter-alia consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the audited financial results for the financial year ended 31st March, 2026 and recommendation of final dividend, if any for the financial year ended 31st March, 2026.
To consider and approve the financial results for the period ended March 31, 2026 and recommendation of dividend, if any
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the quarter and year ended March 31, 2026 and dividend
To consider and approve the Audited Financial Results and Dividend, if any, for the Financial Year ended March 31, 2026
To consider and approve the Audited financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the Audited (Standalone and Consolidated) Financial Results of the Company for the quarter and year ended March 31, 2026 and to recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2026. Further, in continuation to our earlier intimation dated March 26, 2026 regarding closure of Trading Window, we wish to inform you that the Trading Window for dealing in the shares of the Company shall remain closed from April 1, 2026 to May 28, 2026 (both days inclusive).
To consider and approve the Audited (Standalone & Consolidated) Financial Results for the Quarter and Financial Year ended 31st March, 2026 and recommend a dividend for the financial year 2025-26, if any
Board Meeting intimation to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31st, 2026 and any other business matter with the permission of the chair.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and to recommend final dividend for the Financial Year 31st March, 2026, if any.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend, if any
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the quarter and financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and final dividend.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and Fund Raising
To consider and approve the Audited Financial Results and recommend dividend, if any, for the financial year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the Annual Standalone and Consolidated financial results and Statements for the quarter and year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
MARKOLINES : 26-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 26, 2026 to consider and approve the financial results for the period ended March 31, 2026
To consider and approve Audited Standalone and Consolidated Financial Results and to consider recommendation of dividend if any, for the Financial Year ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and final dividend,, if any
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
MOREPENLAB : 26-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 22, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2026, To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the quarter and financial year ended March 31, 2026 and any other business matters with the permission of the Chairman.
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve (a) Audited Standalone and Consolidated Financial Statements for the financial year ended 2025-2026 and for the quarter ended 31st March 2026; (b) Recommendation of final dividend, if any, for the financial year 2025-26; (c) any other subject.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the audited financial statements for the financial year ended March 31, 2026, and recommend final dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the Audited financial results for the quarter and financial year ended March 31, 2026 and dividend.
To consider and approve the audited financial results for the period ended March 31, 2026 and final dividend, if any.
Intimation of meeting of the Board of Directors of Refex Industries Limited to be held on May 26, 2026 inter-alia to consider and approve the Audited Financial results for the Quarter and Year ended March 31, 2026 & to consider and recommend the Final Dividend for the FY 2025-26, if any.
To consider and approve the Audited Standalone and Consolidated financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and the recommendation of the final dividend, if any.
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Fourth Quarter And Financial Year Ended 31st March 2026 And Recommendation Of Final Equity Dividend, If Any.
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026, dividend and Agenda pertaining to ensuing Annual General Meeting of the company.
VLSFINANCE : 26-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 18, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2026, To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended March 31, 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026 and dividend
To consider and approve the financial results for the period ended March 31, 2026
Source: company filings and exchange event calendars. Times shown in local market time when published.
Get daily alerts with full AI analysis of all 132 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Quarterly Results BSE NSE Announcements
🇮🇳 More from India
View all →June 01, 2026
India Pre-Market Regulatory Roundup — June 01, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India Pre-Market Regulatory Roundup — May 31, 2026
India Pre-Market Regulatory Roundup
May 31, 2026
India MCA Corporate Compliance Enforcement — May 31, 2026
India MCA Corporate Compliance Enforcement
May 31, 2026
India RBI Banking Regulatory Enforcement Actions — May 31, 2026
India RBI Banking Regulatory Enforcement Actions